MedPath

再维药业(海南)有限公司

Ownership
-
Established
2022-04-26
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Oxytocin Injection

Product Name
缩宫素注射液
Approval Number
国药准字H20233816
Approval Date
Jun 27, 2023
NMPA

Oxytocin Injection

Product Name
缩宫素注射液
Approval Number
国药准字H20233815
Approval Date
Jun 27, 2023
NMPA

Octreotide Acetate Injection

Product Name
醋酸奥曲肽注射液
Approval Number
国药准字H20223960
Approval Date
Dec 30, 2022
NMPA

Bromhexine Hydrochloride Injection

Product Name
盐酸溴己新注射液
Approval Number
国药准字H20223720
Approval Date
Nov 23, 2022
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath